<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00491426</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00015379</org_study_id>
    <secondary_id>PPRU 10824</secondary_id>
    <nct_id>NCT00491426</nct_id>
  </id_info>
  <brief_title>Antimicrobial PK in Infants With Suspected or Confirmed Infection</brief_title>
  <official_title>Antimicrobial Pharmacokinetics in High Risk Infants (Urinary Proteomics in Antimicrobial/Antifungal-Treated Newborns - add-on Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pediatric Pharmacology Research Units Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to provide a mechanism for the ongoing collection of blood
      and urine samples in newborns that will be used to measure levels of antimicrobial products
      used in the newborn population where there are limited pharmacokinetic data in either
      premature or term infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Greater than 90% of infants born &lt;32 weeks admitted to critical care nurseries are treated
      with antimicrobial agents during their NICU hospitalization. Most antimicrobial products used
      in the neonatal population lack some aspect of pharmacokinetic information specific to
      neonates. Dosing is based largely on pharmacokinetic data from older children or in some
      cases, adults. This study will also establish a bank of urine samples from newborns treated
      with antimicrobial and/or antifungal therapy and to characterize the urinary proteome in
      selected samples. The sites of the NIH-sponsored Pediatric Pharmacology Research Network
      (PPRU) have access to appropriate assays using microliter amounts of serum and a large pool
      of potential subjects to generate meaningful data that will

        1. Guide dosing of commonly used antimicrobial agents, and

        2. Provide preliminary data for future industry and government trials in the nursery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">450</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <description>Subjects &lt;26 weeks gestational age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>26-29 weeks</arm_group_label>
    <description>Subjects 26-29 weeks gestational age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30-32 weeks</arm_group_label>
    <description>Subjects 30-32 weeks gestational age</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ampicillin</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piperacillin/Tazobactam</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acyclovir</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amphotericin B</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ambisome</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anidulafungin</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caspofungin</intervention_name>
    <description>Drug prescribed per routine medical care.</description>
    <arm_group_label>&lt;26 weeks</arm_group_label>
    <arm_group_label>26-29 weeks</arm_group_label>
    <arm_group_label>30-32 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Premature infants &lt;32 weeks gestational age at birth at risk of infections.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants â‰¤32 weeks and 6 days EGA with high probability of receiving one of the
             antimicrobial agents listed are eligible for study.

          -  Age younger than 120 days

          -  Written informed consent from parent or legal guardian

          -  Infants likely to survive beyond 48 hours after enrollment

        Exclusion Criteria:

          -  Failure to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>120 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danny Benjamin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PPRU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Jayne Kennedy, Pharm, D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Louisville-PPRU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosair Children's Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Michigan, Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2007</study_first_submitted>
  <study_first_submitted_qc>June 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2007</study_first_posted>
  <last_update_submitted>November 16, 2012</last_update_submitted>
  <last_update_submitted_qc>November 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infection</keyword>
  <keyword>Anti-Infective Agents</keyword>
  <keyword>Antifungal Agents</keyword>
  <keyword>Proteomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Liposomal amphotericin B</mesh_term>
    <mesh_term>Caspofungin</mesh_term>
    <mesh_term>Piperacillin, tazobactam drug combination</mesh_term>
    <mesh_term>Anidulafungin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Amphotericin B</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Acyclovir</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Penicillanic Acid</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

